These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17874514)

  • 1. Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation.
    Berthier C; Marti HP
    Swiss Med Wkly; 2007 Mar; 137 Suppl 155():109S-114S. PubMed ID: 17874514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation.
    Berthier C; Marti HP
    Swiss Med Wkly; 2006 Dec; 136(49-50):789-94. PubMed ID: 17299656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.
    Berthier CC; Lods N; Joosten SA; van Kooten C; Leppert D; Lindberg RL; Kappeler A; Raulf F; Sterchi EE; Lottaz D; Marti HP
    Kidney Int; 2006 Jan; 69(2):358-68. PubMed ID: 16408127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.
    Ermolli M; Schumacher M; Lods N; Hammoud M; Marti HP
    Transpl Immunol; 2003; 11(2):137-45. PubMed ID: 12799196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions.
    Zaoui P; Cantin JF; Alimardani-Bessette M; Monier F; Halimi S; Morel F; Cordonnier D
    Diabetes Metab; 2000 Jul; 26 Suppl 4():25-9. PubMed ID: 10922970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA.
    Nicholson ML; Waller JR; Bicknell GR
    Br J Surg; 2002 Jul; 89(7):933-7. PubMed ID: 12081746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
    Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
    Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis and matrix metalloproteinases in rat renal allografts.
    Inkinen KA; Soots AP; Krogerus LA; Lautenschlager IT; Ahonen JP
    Transpl Int; 2005 May; 18(5):506-12. PubMed ID: 15819797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of chronic allograft nephropathy.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
    N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers.
    Mas V; Maluf D; Archer K; Yanek K; Mas L; King A; Gibney E; Massey D; Cotterell A; Fisher R; Posner M
    Transplantation; 2007 Feb; 83(4):448-57. PubMed ID: 17318078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM.
    Del Prete D; Anglani F; Forino M; Ceol M; Fioretto P; Nosadini R; Baggio B; Gambaro G
    Diabetologia; 1997 Dec; 40(12):1449-54. PubMed ID: 9447953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.
    Benekareddy M; Mehrotra P; Kulkarni VA; Ramakrishnan P; Dias BG; Vaidya VA
    Synapse; 2008 Aug; 62(8):590-600. PubMed ID: 18509851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection.
    Brook NR; White SA; Waller JR; Bicknell GR; Nicholson ML
    Br J Surg; 2003 Aug; 90(8):1009-14. PubMed ID: 12905557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their inhibitors.
    Kugler A
    Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology].
    Wasilewska A; Taranta-Janusz K; Zoch-Zwierz W; Rybi-Szumińska A; Kołodziejczyk Z
    Przegl Lek; 2009; 66(9):485-90. PubMed ID: 21033407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteases and their tissue inhibitor in cardiac transplantation.
    Aharinejad S; Krenn K; Zuckermann A; Schäfer R; Paulus P; Seebacher G; Wolner E; Grimm M
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):48-51. PubMed ID: 17482473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.